Chia-Ling Chen Selected Research

Chia-Ling Chen Research Topics

Disease

28	Stroke (Strokes) 04/2024 - 03/2010
25	Infections 01/2023 - 01/2012
24	Neoplasms (Cancer) 04/2024 - 04/2008
16	Inflammation (Inflammations) 01/2022 - 07/2009
8	Cerebral Palsy (Spastic Diplegia) 01/2024 - 04/2004
7	Breast Neoplasms (Breast Cancer) 04/2024 - 01/2014
6	Fibrosis (Cirrhosis) 04/2024 - 01/2021
5	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2014
5	Leukemia 05/2023 - 05/2009
5	Ischemic Stroke 08/2021 - 01/2015
5	Necrosis 07/2021 - 01/2010
5	Adenocarcinoma of Lung 09/2019 - 05/2012
4	Lung Neoplasms (Lung Cancer) 05/2023 - 04/2010
3	Asthma (Bronchial Asthma) 04/2024 - 08/2021
3	Pneumonia (Pneumonitis) 01/2022 - 09/2020
3	Hypoxia (Hypoxemia) 08/2021 - 01/2011
3	Acute Kidney Injury (Acute Renal Failure) 07/2021 - 01/2012
3	Streptococcal Infections (Streptococcal Infection) 01/2019 - 01/2013
3	Communicable Diseases (Infectious Diseases) 09/2017 - 01/2010
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2011 - 05/2009
2	Dyslipidemias (Dyslipidemia) 02/2024 - 01/2021
2	Hyperglycemia 01/2023 - 11/2022
2	Body Weight (Weight, Body) 08/2022 - 11/2002
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2022 - 07/2012
2	Cognitive Dysfunction 03/2022 - 11/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2021
2	Obesity 01/2022 - 01/2021
2	Obstructive Sleep Apnea 08/2021 - 01/2020
2	Apnea 08/2021 - 01/2020
2	Deglutition Disorders (Dysphagia) 01/2021 - 04/2014
2	Dengue (Dengue Fever) 12/2020 - 06/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020 - 09/2019
2	Reinfection 01/2019 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 03/2016 - 11/2014
2	Ataxia Telangiectasia (Louis Bar Syndrome) 02/2016 - 05/2012
2	Acute Promyelocytic Leukemia 01/2015 - 03/2014
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2014 - 09/2012
2	Starvation 01/2013 - 11/2012

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 11/2021 - 01/2012
9	Proteins (Proteins, Gene)FDA Link 04/2024 - 08/2011
9	InterferonsIBA 04/2022 - 10/2012
8	Glycogen Synthase (Synthase I)IBA 04/2022 - 05/2009
6	Glycogen Synthase Kinase 3IBA 04/2022 - 10/2011
6	Antiviral Agents (Antivirals)IBA 01/2021 - 06/2013
6	Glycogen Synthase KinasesIBA 01/2018 - 09/2009
5	Propofol (Diprivan)FDA LinkGeneric 02/2024 - 03/2011
5	Cisplatin (Platino)FDA LinkGeneric 07/2021 - 08/2011
5	CeramidesIBA 10/2011 - 04/2008
4	IntegrinsIBA 04/2024 - 10/2019
4	Therapeutic UsesIBA 04/2024 - 07/2011
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 01/2012
4	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 10/2014
4	CaspasesIBA 12/2020 - 11/2012
4	Caspase 3 (Caspase-3)IBA 09/2019 - 11/2012
4	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 09/2010
4	SphingolipidsIBA 10/2011 - 01/2011
4	Type A Botulinum Toxins (Botox)FDA Link 07/2011 - 04/2004
3	OvalbuminIBA 04/2024 - 08/2021
3	PaxillinIBA 04/2024 - 01/2021
3	Anesthetics (Anesthetic Agents)IBA 02/2024 - 03/2011
3	Hypnotics and Sedatives (Sedatives)IBA 08/2021 - 01/2021
3	Small Interfering RNA (siRNA)IBA 01/2021 - 10/2012
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 01/2013
3	LipidsIBA 11/2015 - 04/2008
3	ceramide glucosyltransferaseIBA 08/2015 - 10/2011
3	Interleukin-10 (Interleukin 10)IBA 11/2014 - 09/2009
3	Macrophage Migration-Inhibitory FactorsIBA 10/2014 - 01/2012
2	SialyltransferasesIBA 04/2024 - 01/2021
2	salicylhydroxamic acid (SHAM)IBA 04/2024 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2023 - 10/2019
2	Antineoplastic Agents (Antineoplastics)IBA 04/2023 - 11/2014
2	Poly(A)-Binding Proteins (Poly(A)-Binding Protein)IBA 01/2023 - 11/2022
2	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2022 - 01/2021
2	Viral ProteinsIBA 11/2022 - 01/2017
2	Metalloproteases (Metalloproteinases)IBA 08/2021 - 01/2021
2	DisintegrinsIBA 08/2021 - 01/2021
2	ChemokinesIBA 07/2021 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2017
2	Particulate MatterIBA 11/2020 - 09/2019
2	Butylated Hydroxytoluene (BHT)IBA 12/2019 - 01/2019
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2019 - 01/2018
2	AutoantibodiesIBA 01/2019 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 09/2017 - 01/2015
2	Galectin 3 (LGALS3)IBA 03/2016 - 08/2011
2	TensinsIBA 03/2016 - 10/2015
2	1,4- bis(di(5- hydroxy- 1H- indol- 3- yl)methyl)benzeneIBA 11/2015 - 01/2014
2	AlkaloidsIBA 08/2015 - 05/2012
2	Vinorelbine (Navelbine)FDA LinkGeneric 08/2015 - 07/2014
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 01/2010
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2015 - 08/2011
2	dicarboxydine (DCD)IBA 09/2014 - 07/2012
2	p38 Mitogen-Activated Protein KinasesIBA 11/2012 - 10/2011
2	Annexin A2 (Annexin II)IBA 09/2012 - 10/2009

Therapy/Procedure

18	Therapeutics 09/2023 - 03/2010
10	Activities of Daily Living (ADL) 01/2023 - 04/2010
5	Aftercare (After-Treatment) 01/2023 - 12/2012
5	Mirror Movement Therapy 01/2023 - 10/2017
3	Stroke Rehabilitation 03/2024 - 04/2010
3	Neurological Rehabilitation 01/2020 - 05/2017
3	Drug Therapy (Chemotherapy) 08/2011 - 04/2008